Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Chahine

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|October 23, 1997
Wrangle over rights to BRCA1K Chahine
Nature Biotechnology|November 27, 1998
Amgen battles for EPO in CongressK Chahine
Nature Biotechnology|July 1, 1997
Hemispherx: 300 patents, 20 staffK Chahine
Nature Biotechnology|March 6, 1998
US courts disagree on generic drug exclusivityK Chahine
Nature Biotechnology|October 27, 1998
The importance of "legalese" in biotechnology patentsK Chahine
Nature Biotechnology|March 7, 2001
Amgen preserves erythropoietin monopoly for nowK Chahine
Nature Biotechnology|June 1, 1997
Amgen protects its billion dollar proteinK Chahine
Nature Biotechnology|July 11, 2000
Hatch-waxman changes debatedK Chahine
Nature Biotechnology|August 14, 1998
Patent office resurrects EST debateK Chahine
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|November 21, 2008
[Treatment of a voluminous rhinophyma]K Nadour, R Rtail, K Chahine, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|October 23, 1997
Wrangle over rights to BRCA1K Chahine
Nature Biotechnology|November 27, 1998
Amgen battles for EPO in CongressK Chahine
Nature Biotechnology|July 1, 1997
Hemispherx: 300 patents, 20 staffK Chahine
Nature Biotechnology|March 6, 1998
US courts disagree on generic drug exclusivityK Chahine
Nature Biotechnology|October 27, 1998
The importance of "legalese" in biotechnology patentsK Chahine
Nature Biotechnology|March 7, 2001
Amgen preserves erythropoietin monopoly for nowK Chahine
Nature Biotechnology|June 1, 1997
Amgen protects its billion dollar proteinK Chahine
Nature Biotechnology|July 11, 2000
Hatch-waxman changes debatedK Chahine
Nature Biotechnology|August 14, 1998
Patent office resurrects EST debateK Chahine
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|November 21, 2008
[Treatment of a voluminous rhinophyma]K Nadour, R Rtail, K Chahine, et al.
Pageof 2